Geoffrey Mcdonough
board of directors
medical
PTC Therapeutics
Japan
Biography
Geoffrey McDonough, M.D. has served as a member of PTC's board of directors since November 2012. Since August 2011, Dr. McDonough has served as President and Chief Executive Officer of Swedish Orphan Biovitrum AB (Sobi), a biopharmaceutical company focused on rare diseases. Prior to joining Sobi, Dr. McDonough held several senior leadership positions at Genzyme Corporation from 2002 to June 2011. Prior to joining Genzyme, Dr. McDonough was a practicing internist and pediatrician. Dr. McDonough received a B.A. and a B.Sc. from the University of North Carolina at Chapel Hill and an M.D. from Harvard Medical School.
Research Interest
medical
